Replies to post #6240 on Navidea Biopharmaceuticals Inc (NAVB)

[diddobuyer]

I have a feeling even EMA approval or expanded label in itself will not move the stock either. The revenues have to be substantial or this will Be in limbo, just my hunch as I watch my investment value declining now almost 47%. I could buy more here but i don't want to lose more money.

[diddobuyer]

Lifetech crapital caveats

Need to Raise Additional Funds:
While Navidea has sufficient cash for near
term development, we believe that
Navidea will be required to raise additional funds through the issuance of stock which would be dilutive to existing
shareholdersand could potentially affect the share price.